The headline for 37 °C in 2018 is Digitalising health. In addition to plenary sessions there will be parallel sessions on Digitalising healthcare, Digitalisation in biotech, a Venture Session and Workshops on specific topics. 37 ºC has a carefully crafted program, a stimulating exhibition, B2B meetings and venture session.

Norway has one of the strongest and most admired health-related personal data registries and is a unique location for development of machine learning and artificial intelligence applications for the healthcare sector.

Day 1 – June 19th

09:00 10:00 Registration & Coffee

 Plenary session. Venue: Mastrafjorden

10:00 10:25 Opening and welcome addresses
Speakers
  • Co-Chairs
  • Bent Høie, Norwegian Minister of Health and Care Services
10:25 11:05
Keynote speaker Erik Halvorsen, Director at TMCx Accelerator, Texas Medical Center
Description TBA
11:05 11:35 Coffee break & Mingling
11:35 12:15 Panel: Precision medicine will transform the entire pharmaceutical value chain from research, development, market authorization, to product launch and post-marketing monitoring.
Speakers
  • TBA
  • TBA
  • TBA
Description How will regulatory, reimbursement and business models need to evolve and adapt to encourage innovation while ensuring maximum value is delivered to patients.
Moderator Stephen McAdam, Global Healthcare Director, at DNV GL (OK)
12:15 13:25 Lunch & Mingling

Parallel session: Digitalising healthcare. Venue: Mastrafjorden

13:25 14:05 Panel: Unifying primary and secondary healthcare, and bringing the doctor to your living room with technology
Speakers
  • Thomas Lindner, MD, PhD, Director RAKOS – The Regional Centre for Emergency Medical Research and Development
  • TBA
  • TBA
Description Technology that bridges primary and secondary healthcare and that brings the hospital to our homes. Availibility versus accuracy, human contact and security.
Moderator TBA
14:05 14:45 Panel: The hospital of the future
Speakers
  • Johan Gjendem, Country Division Lead at Siemens Healthcare
  • Ole Paulsen, CEO Headroom Concepts
  • Erik Halvorsen, Director at TMCx Accelerator, Texas Medical Center
  • TBA
Description How a hospital would ideally look like and function if technology were applied in an optimal way. How the use of simulators, augmented reality (AR), virtual reality (VR), robotics is impacting education, training, patient consultancy, staff and organisation.
Moderator Thor Ole Gulsrud, Research Director – Medtech at International Research Institute of Stavanger and Associate Professor II in Health Technology at University of Stavanger

Parallel session: Digitalisation in biotech. Venue: Lysefjorden

13:25 14:05 Panel: In silico medicine
Speakers
  • Joakim Sundnes, Associate Professor and Chief Research Scientist at Simula Research Laboratory
  • Marianne Fyhn, Associate Professor at Oslo University
Description Predictive or “in silico medicine” is the use of computer modelling and simulation in the diagnosis, treatment, prevention of a disease and development of products. Listen to researchers and experts within the field discuss how digitalization will transform medicine and what huge possibilities that lays in the future!
Moderator Adriano Henney, VPH Institute
14:05 14:45 Panel: Utilizing Norwegian health registries for technology development; BigData and personalized medicine – opportunities for both corporates and startups.
Speakers
  • Suzy Scholl, Coordinator of Translational Program in Gynecological Cancer and Head of RAIDS CONSULTING
  • Oddgeir Holmen, IT Project Manager, HUNT Research Centre, Dept. of Public Health and Gen. Practice, NTNU
  • Morten L. Isaksen, PhD, CEO, Bio-Me AS
  • Jan Nygård, CIO at The Cancer Registry of Norway
Description The Norwegian health registries have a huge role to play in order to help develop AI and machine learning. Lessons learned in deCode at Iceland and in Genomic Expression.
Moderator Ketil Widerberg, CEO of Oslo Cancer Cluster

 Workshop. Venue: Snønuten (2nd floor)

(NB. Starting after lunch)
13:25 14:35 Workshop: Food is the new medicine. Hosted by TLSC. (PART 1/2)
Speaker (30 min) Rupert Osborn, CEO IP Pragmatics Limited
Technology presentations (40 min) 1. Egil Greve, CEO at Kappa bioscience, Vitamin K-2
2. Jens Nordahl, VP Sales & Marketing at Smartfish medisical treatment with omega 3
3. Seagarden, Haugesund (TBC)
4. AM Nutrition
Description Food is a most important factor in the prevention of disease.
It is also an important complement to medicine, to cure disease. NOW convergence is coming to the healthcare market !
– Companies from food production, aquaculture, agriculture, biotech and nutraceuticals are all turning their focus to health.
How can Norway’s food industry enter the world health markets?“Let food be thy medicine and medicine be thy food.”
Hippocrates (460-377 B.C.)
Moderator Marius Øgaard, Managing Director at The Life Science Cluster
14:45 15:00 Coffee break & Mingling

B2B Meetings. Venue: Meeting rooms

12:15 17:00 B2B Meetings
Description Start networking here (opening soon), and set up your meetings now.

Venture Session. Venue: Mastrafjorden

15:00 16:30 Venture Session
Companies 1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
Description Company presentations á 7 minutes before a panel of investors.
Moderator TBA

Workshop. Venue: Snønuten (2nd floor)

15:00 16:20 Workshop: Food is the new medicine. Hosted by TLSC (PART 2/2)
Speaker (30 min) Professor Philip Calder BSc(Hons), PhD, DPhil, RNutr, FSB, FAfN Professor of Nutritional Immunology
Technology presentations (20 min) 5. Sjur Svaboe CEO Biolink Group/Kristian Larsen COO Biolink Group, Medpalett
6. Marianne Skov Markussen, Nortura
Panel discussion (30 min)  TBA
Description Food is a most important factor in the prevention of disease.
It is also an important complement to medicine, to cure disease. NOW convergence is coming to the healthcare market !
– Companies from food production, aquaculture, agriculture, biotech and nutraceuticals are all turning their focus to health.
How can Norway’s food industry enter the world health markets?“Let food be thy medicine and medicine be thy food.”
Hippocrates (460-377 B.C.)
Moderator Marius Øgaard, Managing Director at The Life Science Cluster

Workshop. Venue: Uburen (2nd floor)

15:00 16:30 Workshop: How can we accelerate innovation within biotech and life science and use digitalization as a facilitator?
Speakers
  • Anne Kjersti Fahlvik, Executive Director Division of Innovation, Norwegian Research Council
  • Laurent Saunier, Head of Departement of Life Science, Vinnova Sweden
  • Steinar Thoresen, Medical Director, Abbvie
  • Nils Spidsøe, Directro, SINTEF TTO AS
Description How digital technology can make innovation more efficient and shorten the commercialisation processes.
Moderator TBA
19:00 20:30 Social event

Day 2 – June 20th

Plenary session. Venue: Mastrafjorden

08:30 09:30 Registration & Coffee
09:30 09:40
Speakers
  • Co-Chairs
  • TBA
09:40 10:20 Incentivising researchers to commercialise new inventions
Speakers
  • Richard Cowburn, Responsible Corporate Affairs at Karolinska Institutet, Sweden
  • Inger Sandlie, Professor and entrepreneur, Oslo University
  • Henric Rhedin, President of ASTP-Proton
Description Norway spends around 1 billion EUR on R&D in healthcare. This should result in industrial development than what is actually observed. One important instrument could be to incentivise researchers to commercialise before publishing. Lund University has recently introduced such incentives.
Moderator Anders Haugland, Managing Director, Bergen Teknologioverføring AS
10:20 10:50 Coffee break & Mingling
10:50 11:30 Panel: Utilising personal health and patient data in perspective of ethics and security – sharing is caring?
Speakers
  • Chunming Rong, Co-chair of IEEE Blockchain, Chair of IEEE Cloud Computing, CTO of Dataunitor, CTO of bitYoga, Head of CIPSI center at the University of Stavanger
  • Gard O Sundby Thomassen, Assistant Director of Division for Research Computing at the University of Oslo Center for Information Technology
  • TBA
  • TBA
Description How to utilise personal health and patient data in an ethically and security-wise sound manner.
Moderator Kathrine Myhre, CEO Norway Health Tech
11:30 12:10 Panel: 3D printed human tissues
Speakers TBA
Description  TBA
Moderator TBA
12:10 13:20 Lunch & Mingling

Parallel session: Digitalising healthcare. Venue: Mastrafjorden

13:20 14:00 Panel: AI and machine learning – the doctors best friend?
Speakers
  • N.N. from Siemens Healthcare AS
  • Trygve Eftestøl, Professor at University of Stavanger, Head of health technology research group
  • Stein Ørn, MD, PhD, Stein Ørn, Professor Stein Ørn, MD, PhD, University of Stavanger and Senior Consultant Cardiology department at Stavanger University Hospital
  • Emiel Janssen, PhD, Head quantitative and molecular pathology; Managing director laboratory for molecular biology; Head of research group at Department for Pathology at Stavanger University Hospital
  • Steinar Thoresen, Medical Director at Abbvie
Description How can technology enhance the quality and capability of medical personell and healthcare. Examples.
Moderator TBA
14:00 14:40 Remotely controlled surgery vs. Drilling operations
Speakers
  • Jan Egil Wagnild, Manager Digital Services at DNV GL Marine Cybernetics Advisory
  • Ilangko Balasingham, PhD, Professor/Head of Biomedical Sensor Network Research Group, NTNU & Oslo University Hospital – Rikshospitalet
  • Jacob Bergsland, MD, PhD, Cardiac Surgeon, Oslo University Hospital – Rikshospitalet
Description How use technology
Moderator Jon Harald Kaspersen, PhD, Research Director at SINTEF; Nordic Co-Chair of 37 °C

Parallel session: Digitalisation in biotech. Venue: Lysefjorden

13:20 14:00 Panel: Are new antibiotics the solution to the AMR threat?
Speakers
  • John Sigurd Mjøen Svendsen, Professor, UiT The arctic university of Norway
  • Pia Abel zur Wiesch, Researcher, UiT The arctic university of Norway
  • Enrico Baraldi, Professor, Uppsala University/PLATINEA/DriveAB
  • Alexander Wentzel, Senior Research Scientist, SINTEF
Description TBA
Moderator TBA
14:00 14:40 Panel: Re-thinking healthcare
Speakers
  • Tamara Mansfeld, Global Innovation Lead, Pfizer
  • Umair Aslam, eHealth Lead of MSD Norway
  • Arne Peder Blix, CEO Friend Software Corp
  • Kirsten Haugland, Head of department at Kreftforeningen and Board Member of Oslo Cancer Cluster
Description How digital technologies are reshaping healthcare, value chains and business models of pharma companies. To concrete examples: Home care for cancer patients and end-to-end treatment for elderly diabetes
patients. Which other new treatments in the biotech pipelines are suitable for end-to-end treatment outside the hospitals. DNA analysis to identify; ex. My Her(itage) (prostata cancer). Ethics related to information about potential illnesses…
Moderator Erling Nordbø, CEO Aleap Incubator for Health startups
14:40 15:00 Coffee break & Mingling